TickerFacts.

Compare

Nature's Sunshine Products Inc vs BridgeBio Pharma, Inc. vs Zai Lab Ltd vs Mirum Pharmaceuticals, Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearNature's Sunshine Products Inc
NATR		BridgeBio Pharma, Inc.
BBIO		Zai Lab Ltd
ZLAB		Mirum Pharmaceuticals, Inc.
MIRM
Year ended2025-12-312025-12-312025-12-312025-12-31
Revenue$480.14M$502.08M$457.18M$521.31M
Revenue growth (YoY)+5.7%+126.3%+15.0%+54.7%
Gross margin72.4%n/a58.3% (computed)n/a
Operating margin5.2%-104.2%-50.2%-4.2%
Net margin4.3%-146.0%-38.4%-4.5%
Net income$20.45M-$732.94M-$175.54M-$23.36M
EPS (Diluted)$1.06-$3.78-$0.16-$0.47
Operating cash flow$35.32M-$445.91M-$150.79M$55.83M
Free cash flow$28.84M-$447.01M-$158.89M$54.87M
Cash & equivalents$93.89M$570.12M$679.57M$296.68M
Total assets$261.15M$936.02M$1.17B$842.81M
Total liabilities$99.59M$3.01B$456.88M$528.12M
Shareholders' equity$161.55M-$2.09B$715.50M$314.69M
Return on year-end equity12.7%n/a-24.5%-7.4%
Shares outstanding17.51M194.77M1.11B51.90M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearNature's Sunshine Products IncBridgeBio Pharma, Inc.Zai Lab LtdMirum Pharmaceuticals, Inc.
Latest$480.14M
Ended 2025-12-31		$502.08M
Ended 2025-12-31		$457.18M
Ended 2025-12-31		$521.31M
Ended 2025-12-31
1 year earlier$454.36M
Ended 2024-12-31		$221.90M
Ended 2024-12-31		$397.61M
Ended 2024-12-31		$336.89M
Ended 2024-12-31
2 years earlier$445.32M
Ended 2023-12-31		$9.30M
Ended 2023-12-31		$266.72M
Ended 2023-12-31		$186.37M
Ended 2023-12-31
3 years earlier$421.91M
Ended 2022-12-31		$77.65M
Ended 2022-12-31		$212.67M
Ended 2022-12-31		$77.06M
Ended 2022-12-31
4 years earlier$444.08M
Ended 2021-12-31		$69.72M
Ended 2021-12-31		$144.10M
Ended 2021-12-31		$19.14M
Ended 2021-12-31